DEA judge orders agency to respond to allegations of opposing marijuana rescheduling and improper communication with opponents. Cannabis stocks declined in 2024 due to concerns about DEA review.

Advocates accuse Drug Enforcement Administration of blocking the reclassification of cannabis as a Schedule III drug under ...

Shares of cannabis stocks slumped after a company set to testify in the Drug Enforcement Administration's rescheduling hearings accused the agency of obstructing the rulemaking process.

Alexander Malyshev and Sarah Ganley of Carter Ledyard & Milburn LLP discuss what the cannabis sector can expect as 2025 ...

A Drug Enforcement Administration (DEA) judge has ordered the agency to respond to new allegations that it opposes the Biden ...

The DEA rejected a September request from Colorado officials to participate in the United States' historic marijuana ...

Attorneys for a cannabis company and advocacy group that are set to testify in the Drug Enforcement Administration’s (DEA) marijuana rescheduling hearing process beginning this month say new evidence ...

Tilray Brands reported 9% YoY revenue growth in Q2 2025 to $210.95 million. Fiscal 2025 guidance remains strong at $950 ...

The state's recreational cannabis industry has expanded to be one of the biggest cannabis markets in the country. Here's what 2025 will look like.

DEA STYMIED MARIJUANA DRUG DEVELOPMENT - HOWEVER FDA MOVING FORWARD ON CANNABIS DRUG DEVELOPMENT FOR HUNTINGTON'S DISEASE "We ...

The latest announcement is out from Village Farms International ( (VFF) ).

As we rev up in 2025, here’s what I see as the main issues/events to watch (and maybe act on) in the industry: For years, “cannabis litigation” didn’t exist because business was conducted in the ...